mechanism 2,068 words KG: astrocyte
Contents

Astrocyte Dysfunction in Parkinson's Disease

Mechanism Info
Nameastrocyte
Key Genes/ProteinsABCA1, AGER, ALDH1L1, APOE, AQP4, BDNF
Related DiseasesAlzheimer's disease
Linked Hypotheses28 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

Related Hypotheses (120)

Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71
Membrane Cholesterol Gradient Modulators
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Microglial Purinergic Reprogramming
Score: 0.70
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.70
Mitochondrial Transfer Pathway Enhancement
Score: 0.70
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Ocular Immune Privilege Extension
Score: 0.69
Extracellular Matrix Stiffness Modulation
Score: 0.69
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.69
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.68
Context-Dependent CRISPR Activation in Specific Neuronal Sub
Score: 0.68
Flotillin-1 Stabilization Compounds
Score: 0.68
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.68
Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.68
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.68
...
Score: 0.68
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68
Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67
← Prevpg 4/6Next →

Related Analyses (30)

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · completed
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Related Experiments (30)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40
GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40
Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40

See Also (11)

ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: expressed_in
ABCG1 Gene
gene · KG edge: expressed_in
ABCG4 Gene — ATP-Binding Cassette Subfamily G Member 4
gene · KG edge: expressed_in
ADAM10 — A Disintegrin And Metalloproteinase Domain 10
gene · KG edge: activates
ADNP Gene
gene · KG edge: expressed_in

Knowledge Graph (12 edges)

MAP1LC3B expressed_in astrocyte
CB2R expressed_in astrocyte
APOE regulates astrocyte
astrocyte associated_with Multiple sclerosis
NRF2 expressed_in astrocyte
BMAL1 expressed_in astrocyte
NOX4 expressed_in astrocyte
STAT3 regulates astrocyte
reactive_astrocyte associated_with astrocyte
C3 expressed_in astrocyte

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...